Engitix, Morphic Partner to Identify New Ways of Treating Intestinal Fibrosis in IBD Patients
News
Engitix and Morphic Therapeutic announced the start of a research partnership into extracellular matrix targets for treating inflammatory bowel disease (IBD) with intestinal fibrosis, known as fibrostenotic IBD. The extracellular matrix ... Read more